Cargando…

Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status

OBJECTIVES: Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior documented symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Arianna, Zizzo, Gaetano, De Paschale, Massimo, Tamburello, Antonio, Castelnovo, Laura, Faggioli, Paola Maria, Clerici, Pierangelo, Brando, Bruno, Mazzone, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204942/
https://www.ncbi.nlm.nih.gov/pubmed/37220145
http://dx.doi.org/10.1371/journal.pone.0285728
_version_ 1785045934722252800
author Gatti, Arianna
Zizzo, Gaetano
De Paschale, Massimo
Tamburello, Antonio
Castelnovo, Laura
Faggioli, Paola Maria
Clerici, Pierangelo
Brando, Bruno
Mazzone, Antonino
author_facet Gatti, Arianna
Zizzo, Gaetano
De Paschale, Massimo
Tamburello, Antonio
Castelnovo, Laura
Faggioli, Paola Maria
Clerici, Pierangelo
Brando, Bruno
Mazzone, Antonino
author_sort Gatti, Arianna
collection PubMed
description OBJECTIVES: Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior documented symptomatic infection (late convalescents) and fully vaccinated asymptomatic donors (vaccinees). METHODS: Twenty-two convalescents and 13 vaccinees were enrolled. Serum anti-SARS-CoV-2 S1 and N Abs were measured using chemiluminescent immunoassays. QFN was performed following instructions and interferon-gamma (IFN-γ) measured by ELISA. AIM was performed on aliquots of antigen-stimulated samples from QFN tubes. SARS-CoV-2-specific memory CD4(+)CD25(+)CD134(+), CD4(+)CD69(+)CD137(+) and CD8(+)CD69(+)CD137(+) T-cell frequencies were measured by flow cytometry. RESULTS: In convalescents, substantial agreement was observed between QFN and AIM assays. IFN-γ concentrations and AIM(+) (CD69(+)CD137(+)) CD4(+) T-cell frequencies correlated with each other, with Ab levels and AIM(+) CD8(+) T-cell frequencies, whereas AIM(+) (CD25(+)CD134(+)) CD4(+) T-cell frequencies correlated with age. AIM(+) CD4(+) T-cell frequencies increased with time since infection, whereas AIM(+) CD8(+) T-cell expansion was greater after recent reinfection. QFN-reactivity and anti-S1 titers were lower, whereas anti-N titers were higher, and no statistical difference in AIM-reactivity and Ab positivity emerged compared to vaccinees. CONCLUSIONS: Albeit on a limited sample size, we confirm that coordinated, cellular and humoral responses are detectable in convalescents up to 2 years after prior infection. Combining QFN with AIM may enhance detection of naturally acquired memory responses and help stratify virus-exposed individuals in T helper 1-type (T(H)1)-reactive (QFN(pos) AIM(pos) Abs(high)), non-T(H)1-reactive (QFN(neg) AIM(pos) Abs(high/low)), and pauci-reactive (QFN(neg) AIM(neg) Abs(low)).
format Online
Article
Text
id pubmed-10204942
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-102049422023-05-24 Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status Gatti, Arianna Zizzo, Gaetano De Paschale, Massimo Tamburello, Antonio Castelnovo, Laura Faggioli, Paola Maria Clerici, Pierangelo Brando, Bruno Mazzone, Antonino PLoS One Research Article OBJECTIVES: Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior documented symptomatic infection (late convalescents) and fully vaccinated asymptomatic donors (vaccinees). METHODS: Twenty-two convalescents and 13 vaccinees were enrolled. Serum anti-SARS-CoV-2 S1 and N Abs were measured using chemiluminescent immunoassays. QFN was performed following instructions and interferon-gamma (IFN-γ) measured by ELISA. AIM was performed on aliquots of antigen-stimulated samples from QFN tubes. SARS-CoV-2-specific memory CD4(+)CD25(+)CD134(+), CD4(+)CD69(+)CD137(+) and CD8(+)CD69(+)CD137(+) T-cell frequencies were measured by flow cytometry. RESULTS: In convalescents, substantial agreement was observed between QFN and AIM assays. IFN-γ concentrations and AIM(+) (CD69(+)CD137(+)) CD4(+) T-cell frequencies correlated with each other, with Ab levels and AIM(+) CD8(+) T-cell frequencies, whereas AIM(+) (CD25(+)CD134(+)) CD4(+) T-cell frequencies correlated with age. AIM(+) CD4(+) T-cell frequencies increased with time since infection, whereas AIM(+) CD8(+) T-cell expansion was greater after recent reinfection. QFN-reactivity and anti-S1 titers were lower, whereas anti-N titers were higher, and no statistical difference in AIM-reactivity and Ab positivity emerged compared to vaccinees. CONCLUSIONS: Albeit on a limited sample size, we confirm that coordinated, cellular and humoral responses are detectable in convalescents up to 2 years after prior infection. Combining QFN with AIM may enhance detection of naturally acquired memory responses and help stratify virus-exposed individuals in T helper 1-type (T(H)1)-reactive (QFN(pos) AIM(pos) Abs(high)), non-T(H)1-reactive (QFN(neg) AIM(pos) Abs(high/low)), and pauci-reactive (QFN(neg) AIM(neg) Abs(low)). Public Library of Science 2023-05-23 /pmc/articles/PMC10204942/ /pubmed/37220145 http://dx.doi.org/10.1371/journal.pone.0285728 Text en © 2023 Gatti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gatti, Arianna
Zizzo, Gaetano
De Paschale, Massimo
Tamburello, Antonio
Castelnovo, Laura
Faggioli, Paola Maria
Clerici, Pierangelo
Brando, Bruno
Mazzone, Antonino
Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
title Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
title_full Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
title_fullStr Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
title_full_unstemmed Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
title_short Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
title_sort assessing sars-cov-2-specific t-cell reactivity in late convalescents and vaccinees: comparison and combination of quantiferon and activation-induced marker assays, and relation with antibody status
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204942/
https://www.ncbi.nlm.nih.gov/pubmed/37220145
http://dx.doi.org/10.1371/journal.pone.0285728
work_keys_str_mv AT gattiarianna assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT zizzogaetano assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT depaschalemassimo assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT tamburelloantonio assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT castelnovolaura assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT faggiolipaolamaria assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT clericipierangelo assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT brandobruno assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus
AT mazzoneantonino assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus